Christopher J. Shepherd

791 total citations
14 papers, 372 citations indexed

About

Christopher J. Shepherd is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Christopher J. Shepherd has authored 14 papers receiving a total of 372 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Christopher J. Shepherd's work include Prostate Cancer Treatment and Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and MRI in cancer diagnosis (2 papers). Christopher J. Shepherd is often cited by papers focused on Prostate Cancer Treatment and Research (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and MRI in cancer diagnosis (2 papers). Christopher J. Shepherd collaborates with scholars based in United Kingdom, United States and Spain. Christopher J. Shepherd's co-authors include Janet Shipley, Prakash K. Rao, Harvey F. Lodish, Lauren Shields, Edoardo Missiaglia, Bingbing Yuan, David L. Hudson, Siân Rizzo, Daniel Brewer and Ioanna Ledaki and has published in prestigious journals such as Journal of Clinical Oncology, The FASEB Journal and British Journal of Cancer.

In The Last Decade

Christopher J. Shepherd

14 papers receiving 369 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Christopher J. Shepherd United Kingdom 8 174 121 102 98 59 14 372
G. Landberg Sweden 8 250 1.4× 66 0.5× 115 1.1× 87 0.9× 77 1.3× 11 423
Bhavesh Vaidya United States 6 168 1.0× 55 0.5× 175 1.7× 34 0.3× 43 0.7× 6 347
Guohua Rong China 11 109 0.6× 114 0.9× 157 1.5× 65 0.7× 29 0.5× 13 265
Hua Linghu China 13 251 1.4× 91 0.8× 105 1.0× 39 0.4× 54 0.9× 34 415
Mary Stanley United States 7 176 1.0× 159 1.3× 178 1.7× 54 0.6× 31 0.5× 11 397
Joshua Paterson Canada 7 163 0.9× 60 0.5× 118 1.2× 35 0.4× 35 0.6× 11 278
Ilsa Coleman United States 5 203 1.2× 70 0.6× 116 1.1× 114 1.2× 19 0.3× 7 433
Wen Min Lau United States 9 290 1.7× 93 0.8× 173 1.7× 55 0.6× 58 1.0× 10 423
María Giselle Peters Argentina 10 300 1.7× 89 0.7× 177 1.7× 51 0.5× 120 2.0× 17 469
Jung-Ah Hwang South Korea 15 279 1.6× 128 1.1× 152 1.5× 140 1.4× 32 0.5× 23 447

Countries citing papers authored by Christopher J. Shepherd

Since Specialization
Citations

This map shows the geographic impact of Christopher J. Shepherd's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher J. Shepherd with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher J. Shepherd more than expected).

Fields of papers citing papers by Christopher J. Shepherd

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher J. Shepherd. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher J. Shepherd. The network helps show where Christopher J. Shepherd may publish in the future.

Co-authorship network of co-authors of Christopher J. Shepherd

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher J. Shepherd. A scholar is included among the top collaborators of Christopher J. Shepherd based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher J. Shepherd. Christopher J. Shepherd is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
1.
Carmo, Bruno, et al.. (2025). On-table monitoring of prostate MRI could enable tailored utilisation of gadolinium contrast. European Radiology. 35(9). 5701–5709. 2 indexed citations
2.
Shepherd, Christopher J., et al.. (2023). Assessment of deep learning-based reconstruction on T2-weighted and diffusion-weighted prostate MRI image quality. European Journal of Radiology. 166. 111017–111017. 41 indexed citations
3.
Holz, Josefin-Beate, et al.. (2022). Durable response of anaplastic thyroid carcinoma to FS118, a bispecific LAG-3/PD-L1 antibody, after checkpoint inhibitor progression: a case report. Journal for ImmunoTherapy of Cancer. 10(10). e005225–e005225. 6 indexed citations
4.
Garralda, Elena, Ignacio Melero, Guillermo de Velasco, et al.. (2021). 165TiP A first-in-human phase I study of FS222, a CD137/PD-L1 tetravalent bispecific antibody, in patients with advanced malignancies. Annals of Oncology. 32. S1454–S1454. 1 indexed citations
5.
Papadopoulos, K., Timothy A. Yap, Sarina A. Piha‐Paul, et al.. (2021). 1033TiP A first-in-human phase I study of FS120, an OX40/CD137 tetravalent bispecific antibody, in patients with advanced malignancies. Annals of Oncology. 32. S864–S865. 2 indexed citations
6.
Banerjee, Susana, Liz-Anne Lewsley, Andrew R. Clamp, et al.. (2019). OCTOPUS: A randomised, multi-centre phase II umbrella trial of weekly paclitaxel+/- novel agents in platinum-resistant ovarian cancer: Vistusertib. Annals of Oncology. 30. v403–v404. 3 indexed citations
7.
Westin, Shannon N., Jennifer K. Litton, Christopher J. Shepherd, et al.. (2018). Phase I trial of olaparib (PARP inhibitor) and vistusertib (mTORC1/2 inhibitor) in recurrent endometrial, ovarian and triple negative breast cancer.. Journal of Clinical Oncology. 36(15_suppl). 5504–5504. 24 indexed citations
8.
9.
Rao, Prakash K., Edoardo Missiaglia, Lauren Shields, et al.. (2010). Distinct roles for miR‐1 and miR‐133a in the proliferation and differentiation of rhabdomyosarcoma cells. The FASEB Journal. 24(9). 3427–3437. 116 indexed citations
10.
Shepherd, Christopher J., Siân Rizzo, Daniel Brewer, et al.. (2008). TEAD1 and c-Cbl are novel prostate basal cell markers that correlate with poor clinical outcome in prostate cancer. British Journal of Cancer. 99(11). 1849–1858. 73 indexed citations
11.
Shepherd, Christopher J., Siân Rizzo, Ioanna Ledaki, et al.. (2008). Expression profiling of CD133+ and CD133— epithelial cells from human prostate. The Prostate. 68(9). 1007–1024. 49 indexed citations
12.
Mackay, Alan, Jeremy Clark, Christopher J. Shepherd, et al.. (2006). A conditionally immortalized cell line model for the study of human prostatic epithelial cell differentiation. Differentiation. 75(1). 35–48. 10 indexed citations
13.
Hepburn, A. L., Justin C. Mason, Christopher J. Shepherd, et al.. (2006). Both Fcγ and complement receptors mediate transfer of immune complexes from erythrocytes to human macrophages under physiological flow conditionsin vitro. Clinical & Experimental Immunology. 146(1). 133–145. 31 indexed citations
14.
Kimber, Ian, et al.. (1989). Acute-Phase Proteins and the Serological Evaluation of Experimental Contact Sensitivity in the Mouse. International Archives of Allergy and Immunology. 89(2-3). 149–155. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by G. Landberg Breakdown of academic impact, for papers by Bhavesh Vaidya Breakdown of academic impact, for papers by Guohua Rong Breakdown of academic impact, for papers by Hua Linghu Breakdown of academic impact, for papers by Mary Stanley Breakdown of academic impact, for papers by Joshua Paterson Breakdown of academic impact, for papers by Ilsa Coleman Breakdown of academic impact, for papers by Wen Min Lau Breakdown of academic impact, for papers by María Giselle Peters Breakdown of academic impact, for papers by Jung-Ah Hwang
Rankless by CCL
2026